BIO-Key International Inc
NASDAQ:BKYI
Net Margin
BIO-Key International Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | US |
Market Cap | 3.1m USD |
Net Margin |
-106%
|
Country | US |
Market Cap | 3T USD |
Net Margin |
36%
|
Country | US |
Market Cap | 318.1B USD |
Net Margin |
20%
|
Country | US |
Market Cap | 147.2B USD |
Net Margin |
20%
|
Country | US |
Market Cap | 95.6B USD |
Net Margin |
30%
|
Country | US |
Market Cap | 75B USD |
Net Margin |
3%
|
Country | US |
Market Cap | 61.5B USD |
Net Margin |
10%
|
Country | US |
Market Cap | 45.2B USD |
Net Margin |
22%
|
Country | US |
Market Cap | 26.5B USD |
Net Margin |
-7%
|
Country | IL |
Market Cap | 17.1B USD |
Net Margin |
34%
|
Country | US |
Market Cap | 14.5B USD |
Net Margin |
40%
|
Profitability Report
View the profitability report to see the full profitability analysis for BIO-Key International Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on BIO-Key International Inc's most recent financial statements, the company has Net Margin of -106.4%.